Results · Apr-Jun 2026
Indraprastha Medical Corporation Lt Q1 FY27 results
Sales grew 11% to ₹406 crore from ₹365 crore in Apr-Jun 2025.
Operating profit grew 9% to ₹79.8 crore, an operating margin of 19.7% (down 0.4 points from a year ago).
Net profit grew 9% to ₹55.9 crore from ₹51.5 crore in Apr-Jun 2025.
Against Jan-Mar 2026: sales +11%, net profit +34%.
Apr-Jun 2026 vs a year ago
| ₹ crore | Apr-Jun 2026 | Apr-Jun 2025 | Change |
|---|---|---|---|
| Sales | 406.2 | 365.1 | +11% |
| Operating profit (EBITDA) | 79.8 | 73.2 | +9% |
| Operating margin | 19.7% | 20.0% | −0.4 pts |
| Net profit | 55.9 | 51.5 | +9% |
Standalone figures. Margins & ratios change in percentage points (pts).
The last 7 quarters
From the company's results filed on BSE (Standalone). Business numbers only. Education & analysis, not investment advice or a recommendation.